OYST - Oyster Point Pharma Inc. (OYST) CEO Jeffrey Nau on Q3 2021 Results - Earnings Call Transcript
Oyster Point Pharma, Inc. (OYST) Q3 2021 Earnings Conference Call November 4, 2021, 04:30 PM ET Company Participants Daniel Lochner - CFO Jeffrey Nau - President, CEO & Director John Snisarenko - Chief Commercial Officer Conference Call Participants Ken Cacciatore - Cowen Joe Catanzaro - Piper Sandler Anupam Rama - JPMorgan Cory Jubinville - LifeSci Capital Presentation Operator Good evening. And welcome to Oyster Point Pharma's Third Quarter 2021 Earnings Conference Call. My name is Jeff, and I will be the operator today. After the company’s formal remarks, there will be a question-and-answer session. At this time, I would like to turn the call over to Mr. Daniel Lochner, Oyster Point Pharma's Chief Financial Officer. Please go ahead. Daniel Lochner Good evening, everyone. And welcome to the Oyster Point Pharma third quarter earnings conference call for the 3 months ending September 30, 2021. This evening, we issued a press release
For further details see:
Oyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q3 2021 Results - Earnings Call Transcript